Mono-symptomatic Fabry disease in a population with mild-to-moderate left ventricular hypertrophy
Fabry disease (FD) results from a deficiency in the exoglycohydrolase, α-galactosidase A (AGA), an enzyme required for the sequential degradation of glycosphingolipids, which consequently accumulate in the lysosomes of affected cells. An X-linked inherited metabolic disorder, FD has a high incidence...
Main Authors: | Maria Fuller, Rebecca Perry, Madiha Saiedi, Janice M. Fletcher, Joseph B. Selvanayagam |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Molecular Genetics and Metabolism Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426920301439 |
Similar Items
-
Fabry disease: An overlooked diagnosis in adult cardiac patients
by: Meral Kayıkçıoğlu, et al.
Published: (2017-09-01) -
An effect of left ventricular hypertrophy on mild-to-moderate left ventricular diastolic dysfunction
by: Sharma Kattel, MD, et al.
Published: (2016-03-01) -
The production and measurement of left ventricular hypertrophy
by: McDonald, Jeremiah P.
Published: (2018) -
Il coinvolgimento cardiaco nella malattia di Fabry
by: Maurizio Pieroni
Published: (2017-09-01) -
An analysis of electrocardiographic criteria for determining left ventricular hypertrophy
by: Carlos Alberto Gasperin, et al.
Published: (2002-01-01)